Echocardiography (TTE)


Table of Contents

Clinical Case Study and Scenario Exploration

A Case of D-Shaped Left Ventricle: Recognizing Acute Right Ventricular Failure (Written December 13, 2024)

↪ Comparative Case Study: D-Shaped Left Ventricle in Acute Pulmonary Embolism (Written December 13, 2024)

Carotid Ultrasound Findings in a 47-Year-Old Patient (Written March 24, 2025)

Ultrasound‑guided evaluation and management of elevated D‑dimer in a long‑term‑care resident (Written April 11, 2025)

Interpretation of TTE findings in an 85-year-old gentleman (Written June 20, 2025)

TTE findings and hemodynamic management in an elderly patient following traumatic subdural hemorrhage (Written July 11, 2025)

Transthoracic echocardiography assessment in a 92‑year‑old woman (Written July 29, 2025)



Normative and Pathological Values for Severity Classifications

Normative Values Across the Lifespan from Neonates to Adults


Echocardiography Study Notes for Quick Reminder

(A) Right Ventricle: RV Systolic Function, RV Diastolic Function, RV Reference Values, Pulmonary Hypertension Assessment

(B) Right Atrium: RA Pressure Reference, Restrictive Filling Pattern Indicators

(C) Diastolic Dysfunction and Left Atrium: Diastolic Dysfunction Grading, Assessment of Left Atrial Pressure

(D) Valvular Diseases: Dobutamine Stress Test for AS, TS/TR Criteria for Prosthetic Valve, Pulmonary Stenosis Assessment

(E) Surgical Indications: AR, Chronic AR, Aortic Dissection

(F) Other Diseases: Pericarditis Assessment, Pulmonary Embolism 60/60 Sign



Clinical Case Study and Scenario Exploration


A Case of D-Shaped Left Ventricle: Recognizing Acute Right Ventricular Failure (Written December 13, 2024)

Abstract

A middle-aged female patient presented with a two-week history of progressive dyspnea and fluid retention. Imaging studies, including chest radiography and computed tomography (CT), revealed severe pulmonary edema, pleural effusion, and ascites. Transthoracic echocardiography identified a D-shaped left ventricle, suggesting acute right ventricular (RV) pressure overload. Despite the absence of a clear underlying cause, such as pulmonary embolism, her hemodynamic status deteriorated rapidly. This case emphasizes the importance of promptly recognizing acute right heart failure and the need for urgent referral when no immediate etiologic factor is identified.

Introduction

Acute right heart failure can be life-threatening, often progressing rapidly and posing management challenges distinct from chronic right-sided dysfunction. While left-sided heart failure is more common and well-characterized, acute right-sided failure demands prompt identification and intervention due to its potential for rapid clinical decline. Echocardiographic evidence of a D-shaped left ventricle strongly suggests RV pressure overload and can serve as an immediate clue to underlying acute right heart stress. This report details a case in which a patient with acute right ventricular failure and a D-shaped left ventricle was urgently referred for advanced care, highlighting the importance of timely diagnosis and management.

Case Presentation

A female patient in her fifth decade of life presented with a two-week history of progressively worsening dyspnea and edema. Prior to admission, she had been receiving care at a non-specialized medical facility, delaying advanced cardiopulmonary assessment. On evaluation, she exhibited severe respiratory distress and systemic congestion. A chest radiograph demonstrated marked pulmonary edema. Additional CT imaging revealed significant pleural effusions and ascites, yet no evidence of pulmonary embolism or other structural cardiopulmonary abnormalities was noted.

Transthoracic echocardiography revealed a characteristic D-shaped deformation of the left ventricle, reflecting interventricular septal shifting due to elevated RV pressure or volume load. Only mild tricuspid regurgitation (grade I) was observed, which does not align with the profound regurgitation typically seen in chronic right-sided failure, thus suggesting an acute process. Despite extensive evaluation, the immediate precipitant of acute RV strain could not be identified.

Given the patient’s severe condition and the rapid progression of symptoms, initial management focused on stabilizing intravascular volume with intravenous diuretics. With the imminent risk of hemodynamic collapse, the patient was urgently transferred to a tertiary care university hospital for further advanced diagnostic evaluation and potential intervention.



Key Concepts

Background

Why is Right Ventricular Failure Unique?

Pathophysiological Mechanisms Leading to RV Failure:

  1. Increased Afterload: Sudden rises in pulmonary arterial pressure (e.g., acute pulmonary embolism, severe acute pulmonary hypertension).
  2. Direct Myocardial Injury: Isolated RV infarction, myocarditis predominantly affecting the right heart.
  3. Volume Overload: Rapid fluid shifts or conditions causing abrupt RV dilation.
  4. External Constraints: Pericardial tamponade or constrictive processes can indirectly compromise RV filling.

Common Etiologies of Acute RV Failure

Etiology Typical Causes Key Diagnostic Clues
Acute Pulmonary Embolism (PE) Thromboembolic event in PA CT pulmonary angiogram (CTA) findings
Acute Severe Pulmonary HTN Autoimmune flare, acute vasospasm Elevated RV systolic pressures, no PE
Myocarditis (RV Predominant) Viral or inflammatory process Cardiac MRI, biopsy if indicated
Acute RV Infarction Coronary artery occlusion (RCA) ECG changes, coronary angiography
Mechanical Obstructions Tumor, large vegetations, hernia Imaging studies (CT, MRI, echo)

Note: In this case, PE was ruled out early via CT.



Case Presentation (Re-Visited)

Patient Profile:

Initial Findings:

Echocardiography Key Finding:

Suspected Mechanisms in this Case:


Interpreting the D-Shaped LV

Why the LV Becomes D-Shaped:

Implications of a D-Shaped LV:


Differential Considerations in This Case

  1. Acute Pulmonary Hypertension (e.g., autoimmune flare):
    • Possibly Takayasu arteritis or another vasculitis causing sudden rise in PA pressures.
    • Systemic autoimmune conditions can suddenly worsen, triggering acute pulmonary vascular changes.
  2. Myocardial Process (e.g., Isolated RV Myocarditis):
    • Less common, but possible if inflammatory insults selectively target the RV.
  3. Rare Embolic Sources (Non-Thrombotic):
    • Fat or air embolism, though these often have other clinical clues.

Diagnostic and Management Strategies

Initial Diagnostic Approach:

  1. Exclude Common Causes First:
    • Pulmonary embolism ruled out by early CT scan.
    • No pericardial effusion or valvular lesion to suggest tamponade or severe valvular dysfunction.
  2. Assess Hemodynamics:
    • RVSP ~54 mmHg: Elevated, but not as high as in longstanding severe RV failure, supporting an acute event.
  3. Consider Specialized Tests:
    • Autoimmune markers, inflammatory tests.
    • Cardiac MRI or advanced imaging if stable enough.

Initial Management Measures:


Lessons Learned



Conclusion

Acute right ventricular failure presenting with a D-shaped left ventricle on echocardiography can present without classic etiologies like pulmonary embolism. In such scenarios, less common causes such as autoimmune-mediated acute pulmonary hypertension must be considered. Rapid recognition, careful volume management, and urgent referral to a tertiary care center for advanced diagnostic and therapeutic modalities are essential to improve patient outcomes.

Written on December 13th, 2024


D-Shaped Left Ventricle in Acute Pulmonary Embolism (Written December 13, 2024)

This work represents a rewritten interpretation of the original case study by Dr. Gabe Alagna (PGY1) and Dr. Lauren McCafferty, MD, intended to enhance understanding and facilitate learning for others while giving full credit to the original authors. A D-shaped left ventricle (LV) is a significant echocardiographic finding frequently observed when right ventricular (RV) pressures escalate. One critical clinical scenario associated with this pattern is acute pulmonary embolism (PE). For those seeking to broaden their understanding of the D-shaped LV in various clinical scenarios, a related case study is available at Intern Ultrasound of the Month: A Sign of Acute Pulmonary Embolism. This case, originally presented by Dr. Gabe Alagna (PGY1) and edited by Dr. Lauren McCafferty, MD (Alagna & McCafferty, 2024), features a 77-year-old female with a history of end-stage renal disease, heart failure, and lung cancer who presented to the emergency department after experiencing sudden unresponsiveness.

During her resuscitation for pulseless electrical activity (PEA) arrest, a cardiac point-of-care ultrasound was performed, revealing distinct echocardiographic findings indicative of acute PE, including marked RV enlargement and free wall hypokinesis with preserved apical contractility (McConnell’s sign). These findings, in conjunction with her underlying malignancy and abrupt hemodynamic deterioration, heightened the suspicion for an acute PE as the underlying cause of her clinical instability.

By reviewing this additional case, readers can gain a more comprehensive perspective on the various presentations and underlying mechanisms of a D-shaped LV. Comparing different etiologies, such as acute pulmonary embolism versus other causes of acute right ventricular failure, enhances the overall understanding of how this echocardiographic sign can manifest in diverse clinical contexts. Exploring multiple cases will aid in recognizing the nuanced differences and similarities, ultimately contributing to more accurate and timely diagnoses in emergency medicine.

This integrative approach underscores the importance of recognizing specific echocardiographic patterns, like the D-shaped LV and McConnell’s sign, within the broader clinical framework. Such recognition facilitates prompt and appropriate therapeutic interventions, thereby improving patient outcomes in acute and often life-threatening situations.


Case Overview

A 77-year-old female with a complex history, including end-stage renal disease, heart failure, and lung cancer, experienced a sudden change in mental status. She became unresponsive while seated, prompting activation of emergency medical services (EMS). Although initially awake during transport, she deteriorated upon arrival at the emergency department (ED) and suffered a pulseless electrical activity (PEA) cardiac arrest. Advanced Cardiac Life Support (ACLS) protocols were initiated. During a brief return of spontaneous circulation (ROSC), a point-of-care ultrasound (POCUS) examination revealed marked RV enlargement and free wall hypokinesis with relatively preserved apical contractility (McConnell’s sign). These findings raised strong suspicion for an acute PE, especially given the patient’s underlying malignancy and abrupt hemodynamic deterioration.


Key Echocardiographic Findings


Diagnostic Considerations

Table: Key Differences in Echocardiographic Findings Between Acute PE-Related RV Strain and Other Causes

Parameter Acute PE (RV Strain) Other Causes (e.g., RV Ischemia)
McConnell’s Sign Common and highly specific Possible but rare
RV/LV Size Ratio ≥1:1 Frequently observed May or may not be present
D-Shaped LV (Septal Bowing) Pronounced due to pressure load Can occur, but less classically observed
TAPSE Often reduced Varies, depends on underlying pathology

This table illustrates that while several findings may overlap between PE and other etiologies of RV dysfunction, the combination of McConnell’s sign and a D-shaped LV strongly directs attention to acute PE, particularly in the setting of hemodynamic instability and risk factors such as cancer-associated hypercoagulability.


Clinical Impact and Management Strategies

Acute PE spans a broad spectrum of severity, ranging from incidental findings in asymptomatic patients to sudden cardiovascular collapse. Hemodynamically unstable PE, once known as “massive” PE, demands rapid intervention. In this case, the recognition of McConnell’s sign prompted immediate therapeutic decisions. Systemic thrombolysis (IV tPA) was administered during recurrent PEA arrest, leading to ROSC. Subsequent stabilization permitted confirmatory imaging via CT angiography, which demonstrated a saddle PE.

  1. Immediate Stabilization:
    Ensure airway patency, adequate oxygenation, and hemodynamic support. Vasopressors, fluids, and, in select cases, mechanical circulatory support can be employed.
  2. Echocardiographic Assessment:
    Rapid bedside ultrasound can detect RV dilatation, reduced RV contractility, McConnell’s sign, and septal flattening. These findings guide further diagnostic and therapeutic steps, especially when hemodynamic instability precludes safe transfer for CT imaging.
  3. Therapeutic Decision-Making:
    Initiation of anticoagulation is fundamental. In severe cases (e.g., persistent hypotension, recurrent arrest), systemic thrombolysis may be necessary. When systemic therapy is contraindicated or ineffective, catheter-directed therapy or surgical embolectomy might be considered.
  4. Long-Term Management:
    After stabilization, a comprehensive diagnostic workup identifies risk factors, such as malignancy or inherited thrombophilia, informing secondary prevention strategies.

Broader Perspectives for Improved Patient Outcomes

While echocardiographic findings drive urgent decision-making, the integration of clinical context is paramount. In patients with cancer, there is an elevated risk for venous thromboembolism, necessitating a high index of suspicion for PE. Early recognition of McConnell’s sign, combined with an understanding of the patient’s comorbidities, can expedite life-saving interventions. Additionally, careful follow-up and consideration of inferior vena cava filters, long-term anticoagulation, and involvement of a multidisciplinary team (cardiology, pulmonology, hematology, and oncology) can improve patient outcomes.

Incorporating advanced imaging techniques, serial echocardiograms, and emerging biomarkers may further refine the diagnostic pathway. Further research and case studies offer insight into the nuanced interpretation of RV strain patterns, allowing for more targeted and individualized therapy.


References


This refined summary honors the original work, provides comprehensive echocardiographic and clinical context, and presents additional perspectives, aiding in the prompt recognition and management of acute PE.

Written on December 13th, 2024


Carotid Ultrasound Findings in a 47-Year-Old Patient (Written March 24, 2025)

1. Original Question and Responses

View Original Korean

Question (Korean)

f.47환자인데 우측 CCA 140cm/s ICA는 80cm/s 측정되는데 이걸 어떻게 해석해야하나요?
이상해서 측정을 두번했구요
경화반이나 죽상반 협착소견은 없었습니다
CCA velocity가 비정상적으로 높네요

Responses (Korean)

  1. Response 1 (Korean)
    ICA로 가면서 떨어지면 괜찮은거 아닌가요?
    근데 CCA에서 plaque가 없고 IMT가 두껍지 않아도 V 높은 경우가 기저 고혈압이 심하거나
    CCA 탄성이 감소한 경우 아닐까싶은데
    책에보면 수축기 최고속도가 20-40세 100+20m/s, 40-59세 89+17m/s로 나오네요
  2. Response 2 (Korean)
    두꺼워 보이면 약주면 될꺼 아냐?
  3. Response 3 (Korean)
    책에서는 Peak systolic velocity >125 혹은 130cm/sec이상, PSV(ICA)/PSV(CCA)>=2이상이면 NASCET상 50%이상 협착이라는 군요
  4. Response 4 (Korean)
    CCA psv 상승으로 불안하신거같은데.IMT 문제없소. ICA velocity 정상이라서 CCA상승이 큰 문제 없어보이네요. ECA velocity도 문제 없다면 추적검사 해서 체크 해보셔도 될거같네요.
  5. Response 5 (Korean)
    중요한 것은 ICA 속도인 것으로 알고 있고, 자세히 알려면 복잡하지만 수축기 최고 속도 ICA 가 125 이상이면 50% ICA가 막혀서 의미있는 협착으로 본다는 정도를 알면 좋을 것 같습니다.
View English Translation

Question (English Translation)

A 47-year-old female patient shows a peak systolic velocity (PSV) of 140 cm/s in the right common carotid artery (CCA) and 80 cm/s in the internal carotid artery (ICA). How should this be interpreted?
The measurements were repeated because the findings seemed unusual.
There was no evidence of plaque or atherosclerotic stenosis.
The CCA velocity appears abnormally high.

Responses (English Translation)

  1. Response 1 (English Translation)
    If the velocity decreases in the ICA, perhaps there is no major issue.
    Even without plaque or thick intima in the CCA, high velocity can occur if the patient has severe underlying hypertension or if the CCA has reduced elasticity.
    A reference suggests that peak systolic velocity in individuals aged 20–40 is about 100 ± 20 cm/s, and for those aged 40–59, about 89 ± 17 cm/s.
  2. Response 2 (English Translation)
    If it looks thick, wouldn’t giving medication resolve the issue?
  3. Response 3 (English Translation)
    According to a reference, if the peak systolic velocity exceeds 125 or 130 cm/s, or if the ratio PSV(ICA)/PSV(CCA) is ≥2, it suggests ≥50% stenosis based on NASCET criteria.
  4. Response 4 (English Translation)
    The elevated CCA PSV seems to be a concern, but the intima-media thickness (IMT) is normal. Because the ICA velocity is normal, the elevated CCA velocity does not appear to be a significant problem. If the ECA velocity is also normal, regular follow-up examinations might be sufficient.
  5. Response 5 (English Translation)
    The important parameter is the ICA velocity. The details can be complex, but generally, if the ICA peak systolic velocity exceeds 125 cm/s, it implies a 50% ICA blockage that is considered clinically significant stenosis.

2. Explanation, Background, and Analysis

A carotid ultrasound evaluates blood flow in the common carotid artery (CCA), internal carotid artery (ICA), and external carotid artery (ECA). In this particular case, the patient’s CCA peak systolic velocity (PSV) is elevated (140 cm/s) on the right side, whereas the ICA-PSV is 80 cm/s. No plaque or significant intima-media thickening (IMT) is observed.

  1. Key Carotid Ultrasound Parameters

    • Peak Systolic Velocity (PSV)
      • Represents the highest velocity of blood flow during systole (heart contraction).
      • Often compared against established normal ranges or thresholds to assess for possible stenosis.
    • Intima-Media Thickness (IMT)
      • Measures the combined thickness of the intima and media layers of the arterial wall.
      • Normal IMT usually indicates minimal atherosclerotic change, but does not fully exclude early disease.
    • PSV Ratios
      PSV(ICA)/PSV(CCA) is a common index for evaluating the severity of stenosis.
      • Ratios ≥2 often indicate ≥50% ICA stenosis based on certain guidelines (e.g., NASCET).
    • Plaque Assessment
      • B-mode imaging visualizes atherosclerotic plaques or calcifications.
      • Absence of visible plaque greatly reduces the likelihood of significant obstruction.
  2. Normal and Abnormal Ranges: PSV, IMT, and Ratios

    Carotid artery velocity and IMT values vary by age, sex, cardiovascular risk profile, and methodology. Table 1 provides approximate reference ranges and classifications for each major carotid segment (CCA, ICA, ECA), including possible differences by sex if reported in certain references. It is important to note that exact cutoffs differ among studies and clinical protocols.

    Parameter Sex Normal Range Mild Abnormality Moderate Abnormality Severe Abnormality
    PSV (CCA)
    (cm/s)
    M/F¹ ~70–125 cm/s (20–60 yrs)
    IMT <0.9 mm²
    125–140 cm/s 140–180 cm/s >180 cm/s (especially if plaque present)
    PSV (ICA)
    (cm/s)
    M/F¹ <125 cm/s (IMT <0.9 mm) 125–150 cm/s 150–200 cm/s >200 cm/s (≥70% stenosis often suspected)
    PSV (ECA)
    (cm/s)
    M/F¹ ~60–120 cm/s (IMT <0.9 mm) 120–150 cm/s 150–200 cm/s >200 cm/s (unusual unless significant disease exists)
    PSV Ratio
    PSV(ICA)/PSV(CCA)
    M/F¹ <2.0 (suggesting <50% stenosis) 2.0–2.5 (possible ≥50% stenosis) 2.5–4.0 (often 60–70% stenosis) >4.0 (≥70% stenosis likely)
    IMT
    (mm)
    M/F¹ <0.9 mm 0.9–1.1 mm 1.1–1.4 mm >1.4 mm (considered significantly abnormal)
  3. NASCET Criteria and Additional Guidelines

    The North American Symptomatic Carotid Endarterectomy Trial (NASCET) established widely utilized benchmarks for carotid stenosis severity based on angiographic measurements. Ultrasound criteria (PSV, velocity ratios, presence of plaque) have been correlated with these angiographic findings. Frequently cited thresholds include:

    • ICA-PSV ≥125–130 cm/s for ≥50% stenosis
    • ICA-PSV ≥200–230 cm/s for ≥70% stenosis
    • PSV(ICA)/PSV(CCA) ≥2 often suggests ≥50% stenosis
    • PSV(ICA)/PSV(CCA) ≥4 often suggests ≥70% stenosis

    Below is an example summary table correlating Doppler velocity measurements with approximate NASCET-based stenosis grading:

    Stenosis Category (NASCET) ICA-PSV (cm/s) PSV(ICA)/PSV(CCA) Ratio Approx. Luminal Narrowing
    <50% <125 cm/s <2.0 Minimal or no significant stenosis
    50–69% 125–230 cm/s 2.0–4.0 Moderate stenosis
    ≥70% ≥230 cm/s ≥4.0 Severe stenosis

    Clinical decisions often rely on Doppler ultrasound findings combined with plaque visualization, patient symptoms, and risk factor status. If ultrasound findings are equivocal or if the patient is symptomatic, additional imaging (CT/MR angiography) may be warranted.

  4. Analysis for This Patient’s Findings

    1. Elevated Right CCA-PSV (140 cm/s)
      Slightly above general upper-normal limits. However, no plaque is identified, and IMT is not notably thick.
    2. Normal ICA-PSV (80 cm/s)
      • Well below the typical threshold of 125 cm/s that would suggest ≥50% stenosis.
      • PSV ratio (ICA/CCA) <1.0, far from the ≥2.0 cutoff for significant stenosis.
    3. Absence of Plaque
      Suggests that the high CCA velocity is not due to a focal stenosis or atherosclerosis.
    4. Possible Explanations
      Hypertension or reduced arterial compliance could elevate flow velocity.
      Technical Factors: Angle of insonation or sampling location can artificially elevate measured velocities.
  5. Recommendations for Clinical Management

    1. Blood Pressure Optimization
      High systemic blood pressure can affect carotid velocities. Ensuring controlled blood pressure is crucial for vascular health.
    2. Risk Factor Modification
      Smoking cessation, lipid management, glycemic control, and a balanced diet can help prevent atherosclerotic progression.
    3. Periodic Ultrasound Follow-Up
      Repeat carotid ultrasound to monitor any changes in CCA-PSV, ICA-PSV, and IMT, especially if cardiovascular risk factors are present.
    4. Further Imaging if Warranted
      In cases of ambiguous ultrasound findings or symptomatic patients (e.g., transient ischemic attacks), CT/MR angiography may be considered to exclude significant stenosis definitively.

3. Detailed Analysis of This Patient’s Condition and Proposed Approach

Below is an expanded discussion that recaps the key question and the main responses (in English), followed by an analysis.

  1. Recap of the Key Question (English)

    Question:
    A 47-year-old female patient has a right common carotid artery (CCA) peak systolic velocity (PSV) of 140 cm/s, while the right internal carotid artery (ICA) PSV is 80 cm/s. No plaque or significant intima-media thickening is seen. How should this elevated CCA velocity be interpreted?

  2. Recap of the Main Responses (English)

    1. Response 1: Suggests that if the ICA velocity is normal, it might not be a significant issue. Possible explanations for elevated CCA velocity without plaque include severe hypertension or reduced arterial elasticity.
    2. Response 2: Briefly mentions that if the vessel looks thick, medication might help—implying that treatment could be aimed at addressing underlying risk factors.
    3. Response 3: References a standard guideline where PSV >125–130 cm/s and PSV(ICA)/PSV(CCA) ≥2 may indicate ≥50% stenosis.
    4. Response 4: Notes that elevated CCA PSV is not necessarily concerning if the ICA PSV is normal and IMT shows no abnormality.
    5. Response 5: Emphasizes that ICA velocity is the more critical parameter and a threshold of 125 cm/s for ICA PSV is often used to define >50% stenosis.
  3. Analysis of the Responses and Proposed Approach

    • Since no plaque or significant intimal thickening is detected, and the ICA velocity (80 cm/s) is comfortably below the ≥125 cm/s threshold, there is no immediate ultrasound evidence of clinically significant stenosis.
    • The elevated CCA-PSV (140 cm/s) may reflect:
      • Underlying hypertension or arterial stiffness.
      • Technical factors during the ultrasound exam (e.g., Doppler angle or sampling error).
    • Because the ICA-PSV is well within normal limits, standard guidelines (including the NASCET-based criteria) do not support a diagnosis of >50% stenosis.
    • Management at this point primarily involves:
      • Ensuring blood pressure control and addressing other cardiovascular risk factors.
      • Follow-up ultrasounds to detect any emerging plaque or changes in velocity over time.
      • Further imaging (CT/MRA) only if new symptoms arise or if velocities/IMT significantly change in follow-up.
    • This approach aligns with the consensus in the responses: the normal ICA flow strongly suggests no hemodynamically significant stenosis at present.

In conclusion, the elevated CCA velocity alone—without plaque, abnormal IMT, or elevated ICA velocity—likely reflects a low-risk situation. Emphasis should be on general cardiovascular risk management and periodic follow-up, rather than invasive intervention.

References

  1. Bluth EI, Ultrasound: A Practical Approach to Clinical Problems. Thieme Medical Publishers, 2008.
  2. Grant EG, et al. Carotid Artery Stenosis: Gray-Scale and Doppler US Diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229(2):340–346.
  3. Barnett HJM, Taylor DW, Eliasziw M, et al. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis. N Engl J Med 1998;339(20):1415–1425.

Written on March 24, 2025


Ultrasound‑guided evaluation and management of elevated D‑dimer in a long‑term‑care resident (Written April 11, 2025)

Clinical vignette

An 85‑year‑old male resident of a long‑term‑care facility (LTCF) reported progressive exertional dyspnoea. Sputum culture yielded multidrug‑resistant Acinetobacter baumannii (MRAB). Previous episodes of hyperkalaemia had been managed conservatively. The facility possessed point‑of‑care ultrasound (POCUS) but lacked CT and MRI capability.

Three sets of plasma biomarkers were obtained over 48 h:

Day D‑dimer (mg L⁻¹) NT‑proBNP (pg mL⁻¹) Creatinine (mg dL⁻¹)
0 1.24 202 0.73
1 1.18 225 0.72
2 1.20 238 0.74

Values remained mildly but consistently above the upper reference limits for D‑dimer and NT‑proBNP, whereas renal clearance stayed preserved.

Sonographic armamentarium for an elevated D‑dimer

Region‑specific study Principal target Key measurements / signs Diagnostic thresholds Salient limitations
Lower‑extremity compression venous duplex Proximal & distal deep‑vein thrombosis (DVT) Compressibility of common femoral, popliteal, and calf veins; intraluminal echogenicity; colour‑flow augmentation Non‑compressibility or visible thrombus = DVT Limited sensitivity for isolated pelvic or calf DVT; operator dependent
Transthoracic echocardiography (TTE) Right‑ventricular (RV) strain & pulmonary hypertension; left‑ventricular (LV) function RV/LV end‑diastolic diameter ratio, TAPSE, S′ wave, interventricular septal flattening, estimated PASP, LV ejection fraction RV/LV > 1, TAPSE < 17 mm, PASP > 35 mmHg support acute pulmonary embolism (PE); LV EF < 50 % or E/e′ > 14 suggest heart failure PE may exist without RV strain; sub‑costal views sometimes sub‑optimal
Lung ultrasound (LUS) Peripheral emboli, pneumonia, interstitial oedema Pleural‑based wedge‑shaped consolidations, B‑line patterns, pleural effusion, dynamic air bronchograms Wedge lesion without air bronchogram favours PE; confluent B‑lines favour heart failure; focal consolidation with air bronchogram favours pneumonia Central PE not visualised; overlapping patterns in mixed pathology
Inferior vena cava (IVC) & hepatic/portal vein Doppler Volume status, right‑atrial pressure IVC diameter & collapsibility, hepatic vein systolic/diastolic flow IVC > 2.1 cm with < 50 % collapse → RAP > 10 mmHg Confounded by mechanical ventilation & chronic pulmonary disease
Pelvic/iliac venous Doppler Iliac or caval thrombosis when leg duplex negative Colour‑flow and spectral Doppler of common & external iliac veins Absent or continuous monophasic flow suggests proximal obstruction Technical difficulty in obesity or immobility
Upper‑extremity & jugular venous Doppler Catheter‑related thrombosis Compressibility & intraluminal echoes Same as lower‑limb criteria Less standardised; false‑positives with phlebitis

Reference values and graded abnormality thresholds

Sonographic parameter Normal range Mild abnormality Moderate abnormality Severe abnormality
Lower‑extremity duplex
‑ Vein compressibility Complete apposition (< 2 mm residual lumen) Incomplete compression with residual lumen 2–4 mm Non‑compressible segment < 5 cm Non‑compressible segment ≥ 5 cm / visible thrombus
‑ Colour‑flow augmentation ≥ 50 % increase with distal squeeze 30–49 % increase < 30 % increase Absent flow
Transthoracic echocardiography
‑ RV/LV end‑diastolic diameter ratio < 0.90 0.90–1.00 1.01–1.20 > 1.20
‑ TAPSE (mm) ≥ 17 13–16 9–12 < 9
‑ Tricuspid annular S′ (cm s⁻¹) ≥ 10 8–9.9 6–7.9 < 6
‑ Estimated PASP (mmHg) ≤ 30 31–40 41–55 > 55
‑ LV ejection fraction (%) ≥ 52 ♂ / 54 ♀ 41–51 30–40 < 30
Lung ultrasound
‑ B‑lines per intercostal space ≤ 2 3–4 (focal) ≥ 5 (diffuse in ≤ 2 zones) ≥ 5 (diffuse in ≥ 3 zones)
‑ Pleural effusion depth (cm) None / < 0.3 0.3–1.0 1.1–2.0 > 2.0
IVC & hepatic/portal Doppler
‑ IVC diameter & collapse ≤ 2.1 cm with > 50 % collapse 2.2–2.5 cm or 35–49 % collapse 2.6–3.0 cm or 20–34 % collapse > 3.0 cm or < 20 % collapse
‑ Hepatic vein systolic dominance S > D S ≈ D D > S Flow reversal
Pelvic / iliac venous Doppler
‑ Spectral waveform phasicity Triphasic Biphasic Continuous Absent flow / echogenic thrombus
Upper‑extremity / jugular Doppler
‑ Vein compressibility Complete Incomplete < 3 cm Incomplete ≥ 3 cm Non‑compressible / thrombus visualised

Abbreviations: RV – right ventricle; LV – left ventricle; TAPSE – tricuspid annular plane systolic excursion; S′ – tissue Doppler systolic velocity; PASP – pulmonary artery systolic pressure; IVC – inferior vena cava; RAP – right‑atrial pressure; S – systolic wave; D – diastolic wave.

Stepwise diagnostic algorithm in a sono‑only environment

Elevated D‑dimer  →  Clinical VTE probability score
                         │
           ┌─────────────┴─────────────┐
           │                           │
   Low / intermediate            High probability
       probability                      │
           │                           │
Compression venous duplex        Duplex + immediate TTE
           │                           │
    ┌──────┴──────┐              ┌─────┴─────┐
    │             │              │           │
Positive       Negative      RV strain   No RV strain
    │             │              │           │
Anticoag.   TTE + LUS        Treat as    LUS ± repeat
(see § 4)       │            presumptive    duplex
           ┌────┴────┐          PE
           │         │
        PE signs   No PE signs
           │         │
    Anticoag.   Re‑evaluate other

Management pathways based on sonographic findings

Ultrasound outcome Immediate therapy Further measures Treatment caveats in the present case
Proximal DVT or imaging‑confirmed PE Therapeutic anticoagulation with LMWH or a direct oral anticoagulant (DOAC) Continue ≥ 3 months; monitor haemoglobin & platelets; perform periodic duplex to document resolution Monitor serum potassium while on heparin owing to risk of hypo‑aldosteronism‑induced hyperkalaemia
RV strain without visualised DVT/PE Anticoagulation as presumptive PE if no alternate cause Reassess with serial NT‑proBNP & TTE; consider transfer for CT if deterioration Adjust dose for creatinine clearance; weigh bleeding risk in frail elderly
LV systolic/diastolic dysfunction Optimise preload (IVC‑guided), initiate low‑dose loop diuretics, ACEi/ARB/ARNI, β‑blocker as tolerated Repeat NT‑proBNP in 1–2 weeks; titrate therapy Loop diuretics lower potassium; vigilance for hypokalaemia in patient with prior hyperkalaemia
LUS pattern compatible with pneumonia Tailored antimicrobial therapy for MRAB (e.g., high‑dose ampicillin/sulbactam or cefiderocol per susceptibility) Serial LUS to monitor aeration; CRP trend Avoid nephrotoxic agents; adjust doses to preserved GFR
Isolated distal (calf) DVT Surveillance duplex on day 7 and 14 or anticoagulation if extension risk factors present (immobility, active infection) Escalate therapy if thrombus propagates Same potassium/bleeding considerations as above
No abnormal findings Close clinical observation; repeat biomarkers if symptoms evolve Encourage early mobilisation, calf‑pump exercises Maintain vigilance for occult iliac thrombosis

Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.

Written on April 11, 2025


Interpretation of TTE findings in an 85-year-old gentleman (Written June 20, 2025)

An 85-year-old male underwent TTE to evaluate valvular and ventricular function. Normal reference limits follow contemporary recommendations from the American Society of Echocardiography (ASE), American College of Cardiology (ACC) and European Society of Cardiology (ESC).

1. Novisible thrombi in this study
2. Non-RHD:
suspicious severe AS & mild AR (I/IV) d/t senile sclerocalcified AV c LOM
(AVA=0.70/1.87cm2 by 2D/CE, AVAi=0.43cm2/m2 by 2D, Vmax=2.18m/s,
peak/meanPG=19/11mmHg, AV annulus=25.3mm, SVi=40.1ml/m2)
with post stenotic dilatation of ascending aorta=4.2cm
mild to moderate MS & mild MR (I/IV) d/t thickended MV c MAC
(MVA=1.21cm2 by 2D, MDPG=4.49mmHg)
2. Moderate global hypokinesia of LV
3. Enlarged LA (LAVI=58ml/m2) & RA sizes c reduced global LV systolic fx(EF=45%)
4. Moderate RVP (RVSP=58mmHg)
5. Mobile hyperechoic material(=0.58mm) at annulus of mitral valve
r/o calcium debris
6. indeterminate LV filling pattern

Findings and commentary

Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.

Written on June 20, 2025


TTE findings and hemodynamic management in an elderly patient following traumatic subdural hemorrhage (Written July 11, 2025)

An 82-year-old male developed epilepsy after recovery from a traumatic subdural hemorrhage (T-SDH). Transthoracic echocardiography (TTE) performed during routine evaluation revealed ischemic myocardial injury and impaired ventricular function, prompting initiation of low-dose carvedilol for blood-pressure (BP) control.

TTE demonstrated an ischemic insult in the left anterior descending (LAD) coronary artery territory with moderate left-ventricular (LV) systolic dysfunction (left-ventricular ejection fraction = 43%); blood pressure was therefore managed with Dilatrend® 3.125 mg, half tablet.

Interpretation of key findings

ParameterMeasured valueReference rangeClinical meaning
Ischemic territoryLAD distributionSuggests prior anterior-wall infarction or ongoing ischemia
LVEF43 %> 55 % (normal)Moderate systolic dysfunction
Global LV contractilityHypokineticNormokineticReduced stroke volume and cardiac output

Rationale for carvedilol (Dilatrend®) 3.125 mg ½ tablet

  1. Neurohormonal modulation. Carvedilol antagonises β1, β2, and α1 receptors, attenuating the adrenergic drive that aggravates ischemia and LV remodeling.
  2. Mortality benefit in ischemic cardiomyopathy. Clinical trials demonstrate reduced all-cause mortality and rehospitalisation when β-blockers are introduced at low dose and titrated upward in LV dysfunction.
  3. Blood-pressure control with vasodilation. The additional α1 blockade offers gentle peripheral vasodilation, lowering afterload without provoking reflex tachycardia.
  4. Low starting dose for frailty. A half-tablet (≈ 1.56 mg) minimises initial bradycardia or hypotension in an elderly, potentially volume-sensitive patient recovering from intracranial pathology.

Suggested up-titration schedule*

Time intervalProposed dose (bid)Haemodynamic targetMonitoring
Week 0 – 21.56 mgSBP > 100 mmHg, HR > 60 bpmOrthostatic BP, dizziness, fatigue
Week 3 – 43.125 mgStable BP, HR 55-70 bpmSerum electrolytes, renal function
> Week 56.25 mgOptimal neurohormonal blockadeSigns of decompensation, CNS symptoms

*Dose escalation contingent on tolerance; slower titration advisable in orthostatic intolerance.

Clinical considerations

Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.

Written on July 11, 2025


Transthoracic echocardiography assessment in a 92‑year‑old woman (Written July 29, 2025)

I. Patient background

II. Quantitative echocardiographic findings

1. Normal sized cardiac chambers with normal global left‑ventricular systolic function (EF: 67 %).

2. Relaxation abnormality of LV filling pattern (E/e′: 14).

3. Moderate circumferential pericardial effusion without hemodynamic significance:
   • LV posterior: 1.62 cm
   • LV apex: 1.71 cm
   • RV side: 1.77 cm
   • RA side: 0.35 cm

4. Concentric left‑ventricular hypertrophy.

5. Slightly dilated sinus of Valsalva (36 mm) and ascending aorta (37 mm).

III. Guideline‑based evaluation

  1. Left‑ventricular size and systolic function

    ParameterNormalPatientInterpretation
    LVEF≥ 53 % (women)67 %Normal
    LV internal dimensions / volumesWithin reference rangeNormal by reportNo dilation
  2. Diastolic function  –  grading criteria

    CriterionGradePatient
    I (impaired relaxation)II (pseudonormal)III (restrictive, reversible)IV (restrictive, fixed)
    E/A ratio< 0.80.8–2.0> 2.0> 2.0Not provided*
    Average E/e′< 1414–15> 15> 1514
    Tricuspid regurgitation Vmax< 2.8 m/s> 2.8 m/s> 2.8 m/s> 2.8 m/sNot provided
    LA volume index< 34 mL/m²> 34 mL/m²> 34 mL/m²> 34 mL/m²Not provided
    • *Given the reported “relaxation abnormality” and borderline E/e′ of 14, the pattern is most compatible with Grade I (impaired relaxation) with borderline filling pressures.
  3. Pericardial effusion size classification

    Maximum separationClassificationPatient (RV side 1.77 cm)
    < 1.0 cmMildModerate
    1.0–2.0 cmModerate
    > 2.0 cmLarge

    No hemodynamic compromise is documented; therefore, tamponade physiology is absent.

  4. Left‑ventricular hypertrophy (LVH)

    IVS / PW thicknessNormalLVH thresholdPatientInterpretation
    Posterior wall< 1.0 cm (women)≥ 1.1 cm1.62 cmConcentric LVH
    Interventricular septum*< 1.0 cm≥ 1.1 cmNot provided
    • *Septal thickness was not included but concentric geometry is inferred from concentric wall thickening and preserved cavity size.

    Geometry pattern Left ventricular mass index (LVMI) Relative wall thickness (RWT)
    Normal geometry Normal (< 95 g/m² in women, < 115 g/m² in men) Normal (≤ 0.42)
    Concentric remodeling Normal (< 95 g/m² in women, < 115 g/m² in men) Increased (> 0.42)
    Concentric hypertrophy Increased (≥ 95 g/m² in women, ≥ 115 g/m² in men) Increased (> 0.42)
    Eccentric hypertrophy Increased (≥ 95 g/m² in women, ≥ 115 g/m² in men) Normal (≤ 0.42)
  5. Aortic root and ascending aorta dimensions

    SegmentUpper normal (women, age > 40)PatientInterpretation
    Sinus of Valsalva≤ 34 mm36 mmSlightly dilated
    Ascending aorta≤ 35 mm37 mmSlightly dilated

IV. Integrated assessment

V. Clinical implications

  1. Blood‑pressure optimization: Intensify antihypertensive strategy to limit further hypertrophic remodeling and aortic dilatation.
  2. Volume management: Coordinate with dialysis team to achieve euvolemia, thereby reducing left‑atrial pressure and diastolic filling pressures.
  3. Pericardial effusion monitoring: Repeat echocardiography if new symptoms (dyspnea, orthopnea, hypotension) occur or if an inflammatory etiology is suspected.
  4. Serial aortic imaging: Consider annual echocardiographic or computed‑tomographic surveillance; expedite if growth > 3 mm appears within a year.
  5. Comprehensive geriatric cardiac care: Continue multidisciplinary follow‑up focusing on frailty, cerebrovascular prevention, and dialysis‑related cardiovascular risk.

VI. Key teaching points

Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.

Written on July 29, 2025


Normative and Pathological Values for Severity Classifications

Normative Values Across the Lifespan from Neonates to Adults

This section presents a peer-reviewed compilation of normative values for echocardiographic measurements, spanning neonates, pediatric patients, and adults. It serves as a critical reference for clinicians, ensuring accurate interpretation of echocardiographic data across different age groups and enhancing diagnostic precision in various clinical scenarios.



Echocardiography Study Notes for Quick Reminder

This quick reference guide provides a synthesized overview of key echocardiography concepts, focusing on the relationship between echocardiographic findings and underlying pathophysiological mechanisms. Designed to aid in the comprehensive assessment and management of cardiovascular conditions, it highlights how specific echocardiographic results correlate with various cardiac pathologies. Drawn from my personal study notes, this summary serves as a helpful reminder of essential materials, though I cannot guarantee the absolute accuracy of these notes.


(A) Right Ventricle

RV Systolic Function

Parameter
Abnormal
RV EF (%)
< 45
TASPE (mm)
< 17
s’ (cm/s)
< 9.5
RV MPI (pulsed)
> 0.43
RV MPI (tissue)
> 0.54
2D Strain (%)
< -20
FAC (Fractional Area Change, %)
< 35
RV Wall Thickness (mm)
< 5

RV Diastolic Function

Parameter
Abnormal
RVOT PLAX Dist (mm)
≥ 27
RVOT PLAX Prox (mm)
≥ 33
RVOT PSAX (mm)
≥ 36
FAC (%)
≤ 33

Parameter
Normal
Impaired
Relaxation
Pseudo
Normal
Restrictive
E/A
0.8 ~ 2.1
< 0.8
0.8 ~ 2.1
> 2.1
E/e'
< 6
< 6
> 6
> 6
DT (msec)
> 120
> 120
> 120
< 120

RV Reference Values

Parameter
Normal
Abnormal
Basal RV Diameter (cm)
2-2.8
> 2.8
Mid RV Diameter (cm)
2.7-3.3
> 3.3
RVOT Diameter (cm) (Above Aorta)
2.5-2.9
> 2.9
RVOT Diameter (cm) (Above Pulmonary Valve)
1.7-2.3
> 2.9
RV Apex to Base (cm)
7.1-7.9
> 7.9
RV End-Diastolic Area (cm²)
11-28
N/A
RV End-Systolic Area (cm²)
7.5-16
N/A
RV FAC (%)
32-60
N/A
TAPSE (cm)
1.5-2
N/A

Pulmonary Hypertension Assessment

Parameter
Value
RVSP (mmHg)
< 35
RA pressure (mmHg)
3-5
PASP (mmHg)
< 25
RVDP (mmHg)
8-15
mPAP (mmHg)
10-20
RV FAC (%)
> 35
TAPSE (mm)
< 17



(B) Right Atrium

RA Pressure Reference

IVC Diameter (cm)
Collapse (%)
RA Pressure (mmHg)
≤ 1.7
> 50
0-5
> 1.7
< 50
10-20

IVC Diameter (cm)
Collapse (%)
RA Pressure (mmHg)
≤ 2.1 cm
≥ 50 %
0-5
≤ 2.1 cm
< 50 %
5-10
> 2.1 cm
≥ 50 %
5-10
> 2.1 cm
< 50 %
10-20

IVC Collapse (%)
Hepatic Vein Flow
RA Pressure (mmHg)
> 50
Vs > Vd
0-5
> 50
Vs = Vd
5-10
< 50
Vs < Vd
10-15
< 50
Vs << Vd
15-20

Restrictive Filling Pattern Indicators

Parameter
Value
Pulmonary Venous S:D Ratio
< 1
IVRT (msec)
< 70
PacT



(C) Diastolic Dysfunction and Left Atrium

Diastolic Dysfunction Grading

Parameter
Normal
Abnormal
(Mild)
PseudoNormal
(Moderate)
Restrictive
(Severe)
E/A Ratio
> 1
< 1
> 1
> 1.5
DT (ms)
< 220
> 200
< 150
< 150
P(LA) (mmHg)
6~12
8~14
15~22
> 22
e' (cm/s)
> 10
8.5~10
< 8.5
N/A
e'/a'
> 1
0.5~1
< 1
N/A

Parameter
Normal
Grade I
Grade II
Grade III
E/A Ratio
> 1
< 0.8
> 2
> 2
DT (ms)
< 200 ms
> 200 ms
< 160 ms
< 160 ms
E/e'
< 8
< 8
> 12
> 15

Parameter
Normal
Grade I
Grade II
Grade III
Grade IV
E/A Ratio
1-1.5
< 1
0.8-1.5
> 2.0
> 2.0
DT (ms)
> 160
> 200
160-200
< 160
< 160

Assessment of Left Atrial Pressure

Parameter
Normal
P(LA) ↑
E/A Ratio
< 1
≥ 2
E (cm/s)
< 50
N/A
DT (ms)
170~260
< 150
Septal E/e'
≤ 8
≥ 15
Lateral E/e'
N/A
≥ 12
LA Vol (mL/m²)
< 34
N/A
Valsalva E/A
< 0.5
N/A



(D) Valvular Diseases

Dobutamine Stress Test for AS

Parameter
True AS
Pseudo AS
Vmax (m/sec)
≥ 4.0 (increases significantly, ⇑)
a slight increase (↑)
AVA (cm²)
≤ 1.0 cm² (stable or decreases, ↔ ↓)
increased (↑)
Mean Gradient
increases significantly (⇑)
a modest increase (↑)


TS Criteria for Prosthetic Valve

Parameter
Abnormal
Peak Velocity (m/s)
> 1.7
Mean Gradient (mmHg)
≥ 5
PHT (ms)
≥ 230

TR Criteria for Prosthetic Valve

Parameter
Normal
Abnormal
Jet Area (cm²)
< 5
> 10
VC Width (cm)
N/A
> 0.7


Pulmonary Stenosis Assessment

Parameter
Mild
Severe
Peak Velocity (m/s)
< 3
> 4
Peak Gradient (mmHg)
< 36
> 64



(E) Surgical Indications

Surgical Indications for AR

Parameter
Value
End-systolic LV dimension
> 5.0 cm
EF
< 50%
Diastolic LV dimension
> 6.5 cm

Surgical Indications for Chronic AR

Parameter
Value
EF (%)
< 50
End-systolic LV dimension (cm)
> 5.0
End-diastolic LV dimension (cm)
> 6.5

Surgical Indications for Aortic Dissection

Case
Value
Dilated aorta
≥ 55 mm
Bicuspid valve, aortic sinus
> 50 mm
Severe AS or AR
> 45 mm



(F) Other Diseases

Pericarditis Assessment

Parameter
Constrictive
Restrictive
Septal e' (cm/s)
> 8 (septal e’ > lateral e’)
< 8 (septal e’ < lateral e’)
Hepatic Vein Reversal
During expiration
During inspiration

Pulmonary Embolism 60/60 Sign

Parameter
Value
PVSP (mmHg)
< 60 (Pulmonary Valve Systolic Pressure)
PAcT (msec)
< 60 (PAAT, Pulmonary Arterial Acceleration Time)



A Collection of Readings on Hemodynamics, for Echocardiography

(A) Dynamics of the Vascular System: Interaction with Heart (2nd edition), by John K-J Li

This foundational text explores the intricate dynamics of the vascular system and its interaction with the heart, offering a detailed understanding of hemodynamic principles. The book emphasizes the physiological and mechanical aspects of blood flow and pressure, and their implications for cardiac function, providing essential knowledge for those studying or practicing echocardiography.

Back to Top